Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02712385 : SPRITE - A Feasibility and Pilot Study
PhasePhase 1/Phase 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- 18 years of age or older

- male or female

- attendee at a participating TIA clinic within 4 weeks of a first suspected TIA

- diagnosed with a TIA or 'minor' stroke, due to atherosclerosis or small vessel
occlusion (diagnosis based on the TOAST classification system (69)(70), following
neurological examination and neuroimaging (32)).

Exclusion Criteria:

- patients who have experienced more than one TIA and/or stroke

- inability to give informed consent

- contra-indication for exercise training, based on guidelines of the American College
of Sports Medicine(72)
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557